Cytokine release syndrome is regarded as the driver of coronavirus disease 2019 (COVID-2019) inflammation, and multiple studies have demonstrated that CXCL9 is associated with the severity of COVID-2019 (28, 29). Here, CXCL9 is linked to COVID-19.